AR004364A1 - Compuesto derivado de pirazol, procedimiento para su preparacion y composicion farmaceutica que lo contiene. - Google Patents
Compuesto derivado de pirazol, procedimiento para su preparacion y composicion farmaceutica que lo contiene.Info
- Publication number
- AR004364A1 AR004364A1 ARP960105525A ARP960105525A AR004364A1 AR 004364 A1 AR004364 A1 AR 004364A1 AR P960105525 A ARP960105525 A AR P960105525A AR P960105525 A ARP960105525 A AR P960105525A AR 004364 A1 AR004364 A1 AR 004364A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- hydrogen
- substituents
- alkoxy
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Compuesto de fórmula (I), en donde: X1 representa un grupo -NR1R2, o un grupo -OR2; G2, G3, G4, G5, G6 y W2, W3, W4, W5, W6 son idénticos o diferentes,y representan cada uno independientemente hidrógeno, un átomo de halógeno, un (C1-C4)-alquilo, un (C1-C4)-alcoxi, un trifluormetilo, un nitro, un (C1-C4)-alquiltio; con la condición de que por lo menos uno de los substituyentes G2, G3, G4, G5, G6 y por lo menos uno de los substituyentes W2, W3, W4, W5, W6 seandiferentes de hidrógeno; R1re presenta hidrógeno o un (C1-C4)-alquilo; R2 representa un radical carbocíclico no aromático en (C3-C15) no substituido osubstituido una o varias veces por un substituyente elegido entre: un átomo de halógeno, un (C1-C4)-alquilo, un (C1-C4)- alcoxi; R3 representa hidrógeno o ungrupo -CH2-R6; R4 y R5 representan cada uno independientemente un hidrógeno, un (C1-C4)-alquilo o un trifluorometilo; o bien R4 representa hidrógeno y R5 y W4juntos constituyen un radical etileno o un radicaltrimetil eno; R6 representa hidrógeno, o cuando los substituyentes G2, G3, G4, G5 y/o G6 son distintos deun (C1-C4)-alquilo, R6 representa hidrógeno, un (C1-C4)-alquilo, un fluor, un hidroxi, un (C1-C5)-alcoxi, un (C1-C5)-alquiltio, unhidroxi(C1-C5)-alco xi, unciano, un (C1-C5)-alquil-sulfinilo, un (C1-C5)-alquilsulfonilo; así como sus sales.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9514547A FR2742148B1 (fr) | 1995-12-08 | 1995-12-08 | Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
AR004364A1 true AR004364A1 (es) | 1998-11-04 |
Family
ID=9485291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960105525A AR004364A1 (es) | 1995-12-08 | 1996-12-06 | Compuesto derivado de pirazol, procedimiento para su preparacion y composicion farmaceutica que lo contiene. |
Country Status (34)
Country | Link |
---|---|
US (1) | US5925768A (es) |
EP (2) | EP0868420B1 (es) |
JP (1) | JP3510270B2 (es) |
KR (1) | KR100488610B1 (es) |
CN (1) | CN1101813C (es) |
AR (1) | AR004364A1 (es) |
AT (1) | ATE191211T1 (es) |
AU (1) | AU718763B2 (es) |
BR (1) | BR9611986A (es) |
CA (1) | CA2239489C (es) |
CZ (1) | CZ294307B6 (es) |
DE (1) | DE69607484T2 (es) |
DK (1) | DK0868420T3 (es) |
EE (1) | EE04674B1 (es) |
ES (1) | ES2148820T3 (es) |
FR (1) | FR2742148B1 (es) |
GR (1) | GR3033626T3 (es) |
HU (1) | HUP9901244A3 (es) |
IL (1) | IL124801A (es) |
IS (1) | IS4765A (es) |
MX (1) | MX9804565A (es) |
MY (1) | MY115228A (es) |
NO (1) | NO310683B1 (es) |
NZ (1) | NZ323962A (es) |
PL (1) | PL186466B1 (es) |
PT (1) | PT868420E (es) |
RU (1) | RU2170230C2 (es) |
SI (1) | SI0868420T1 (es) |
SK (1) | SK283706B6 (es) |
TR (1) | TR199801041T2 (es) |
TW (1) | TW402594B (es) |
UA (1) | UA44913C2 (es) |
WO (1) | WO1997021682A1 (es) |
ZA (1) | ZA9610299B (es) |
Families Citing this family (97)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998041519A1 (en) * | 1997-03-18 | 1998-09-24 | Smithkline Beecham Corporation | Novel cannabinoid receptor agonists |
US20010009965A1 (en) * | 1998-05-04 | 2001-07-26 | Alexandros Makriyannis | Novel analgesic and immunomodulatory cannabinoids |
US7589220B2 (en) * | 1998-06-09 | 2009-09-15 | University Of Connecticut | Inhibitors of the anandamide transporter |
US7897598B2 (en) * | 1998-06-09 | 2011-03-01 | Alexandros Makriyannis | Inhibitors of the anandamide transporter |
US7161016B1 (en) | 1998-11-24 | 2007-01-09 | University Of Connecticut | Cannabimimetic lipid amides as useful medications |
US7276613B1 (en) | 1998-11-24 | 2007-10-02 | University Of Connecticut | Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
HUP0203437A3 (en) | 1999-03-22 | 2003-07-28 | Immugen Pharmaceuticals Inc So | Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases |
US6566560B2 (en) | 1999-03-22 | 2003-05-20 | Immugen Pharmaceuticals, Inc. | Resorcinolic compounds |
US6900236B1 (en) | 1999-10-18 | 2005-05-31 | University Of Connecticut | Cannabimimetic indole derivatives |
US8084467B2 (en) * | 1999-10-18 | 2011-12-27 | University Of Connecticut | Pyrazole derivatives as cannabinoid receptor antagonists |
JP2003511469A (ja) | 1999-10-18 | 2003-03-25 | ユニバーシティ オブ コネチカット | 抹消カンナビノイド受容体(cb2)選択的配位子 |
US6943266B1 (en) | 1999-10-18 | 2005-09-13 | University Of Connecticut | Bicyclic cannabinoid agonists for the cannabinoid receptor |
US7119108B1 (en) | 1999-10-18 | 2006-10-10 | University Of Connecticut | Pyrazole derivatives as cannabinoid receptor antagonists |
US7393842B2 (en) * | 2001-08-31 | 2008-07-01 | University Of Connecticut | Pyrazole analogs acting on cannabinoid receptors |
US7741365B2 (en) * | 1999-10-18 | 2010-06-22 | University Of Connecticut | Peripheral cannabinoid receptor (CB2) selective ligands |
JP2003512357A (ja) * | 1999-10-18 | 2003-04-02 | ユニバーシティ オブ コネチカット | カンナビノイドレセプタ拮抗物質としてのピラゾール誘導体 |
FR2800372B1 (fr) * | 1999-11-03 | 2001-12-07 | Sanofi Synthelabo | Derives tricycliques d'acide 1-benzylpyrazole-3- carboxylique, leur preparation, les medicaments en contenant |
AU2001296402A1 (en) * | 2000-09-28 | 2002-04-08 | Immugen Pharmaceuticals, Inc. | Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation |
AU2002213429A1 (en) * | 2000-09-28 | 2002-04-08 | Immugen Pharmaceuticals, Inc. | Antiviral methods and compounds |
US8449908B2 (en) | 2000-12-22 | 2013-05-28 | Alltranz, Llc | Transdermal delivery of cannabidiol |
EP1361876A4 (en) * | 2001-01-26 | 2004-03-31 | Univ Connecticut | NEW CANNABIMIMETIC LIGANDS |
ATE478670T1 (de) | 2001-01-29 | 2010-09-15 | Univ Connecticut | Rezeptor-selektive cannabimimetische aminoalkylindole |
US7067539B2 (en) * | 2001-02-08 | 2006-06-27 | Schering Corporation | Cannabinoid receptor ligands |
US7507767B2 (en) * | 2001-02-08 | 2009-03-24 | Schering Corporation | Cannabinoid receptor ligands |
CA2452881C (en) * | 2001-07-13 | 2012-03-06 | University Of Connecticut | Novel bicyclic and tricyclic cannabinoids |
WO2003007887A2 (en) * | 2001-07-20 | 2003-01-30 | Merck & Co., Inc. | Substituted imidazoles as cannabinoid receptor modulators |
CA2457922A1 (en) * | 2001-08-31 | 2003-03-13 | University Of Connecticut | Novel pyrazole analogs acting on cannabinoid receptors |
WO2003035005A2 (en) * | 2001-10-26 | 2003-05-01 | University Of Connecticut | Heteroindanes: a new class of potent cannabimimetic ligands |
EP1444203A1 (en) | 2001-11-14 | 2004-08-11 | Schering Corporation | Cannabinoid receptor ligands |
WO2003061699A1 (fr) * | 2001-12-27 | 2003-07-31 | Japan Tobacco, Inc. | Remedes pour affections allergiques |
US20040171613A1 (en) * | 2001-12-27 | 2004-09-02 | Japan Tobacco Inc. | Therapeutic agent for non-immediate type allergic diseases |
WO2003075917A1 (en) * | 2002-03-08 | 2003-09-18 | Signal Pharmaceuticals, Inc. | Combination therapy for treating, preventing or managing proliferative disorders and cancers |
CN1652766A (zh) * | 2002-03-18 | 2005-08-10 | 免疫力药品有限公司 | 间苯二酚和大麻素的局部制剂及其施用方法 |
US6825209B2 (en) | 2002-04-15 | 2004-11-30 | Research Triangle Institute | Compounds having unique CB1 receptor binding selectivity and methods for their production and use |
CA2487346A1 (en) | 2002-06-19 | 2003-12-31 | Schering Corporation | Cannabinoid receptor agonists |
US6972291B2 (en) * | 2002-07-02 | 2005-12-06 | Bernstein Richard K | Method for reducing food intake |
UY27939A1 (es) * | 2002-08-21 | 2004-03-31 | Glaxo Group Ltd | Compuestos |
ES2273077T3 (es) * | 2002-08-21 | 2007-05-01 | Glaxo Group Limited | Derivados de 2-fenilamino-4-trifluorometil-5 (bencil- o piridin-4-il-metil) carbamoilpirimidina como moduladores selectivos del receptor cannabinoide cb2. |
EP1545502A4 (en) | 2002-08-23 | 2008-12-24 | Univ Connecticut | KETO CANNABINOIDS WITH THERAPEUTIC INDICATIONS |
GB0222493D0 (en) * | 2002-09-27 | 2002-11-06 | Glaxo Group Ltd | Compounds |
GB0222495D0 (en) * | 2002-09-27 | 2002-11-06 | Glaxo Group Ltd | Compounds |
US7765162B2 (en) * | 2002-10-07 | 2010-07-27 | Mastercard International Incorporated | Method and system for conducting off-line and on-line pre-authorized payment transactions |
AU2003267728A1 (en) * | 2002-10-18 | 2004-05-04 | Pfizer Products Inc. | Cannabinoid receptor ligands and uses thereof |
US7129239B2 (en) * | 2002-10-28 | 2006-10-31 | Pfizer Inc. | Purine compounds and uses thereof |
ES2327515T3 (es) | 2002-11-25 | 2009-10-30 | Schering Corporation | Ligandos de receptores de cannabinoides. |
US7247628B2 (en) * | 2002-12-12 | 2007-07-24 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
US7329658B2 (en) * | 2003-02-06 | 2008-02-12 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
US7176210B2 (en) * | 2003-02-10 | 2007-02-13 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
EP1606019A1 (en) * | 2003-03-07 | 2005-12-21 | The University Court of The University of Aberdeen | Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders |
TW200505902A (en) * | 2003-03-20 | 2005-02-16 | Schering Corp | Cannabinoid receptor ligands |
US7141669B2 (en) * | 2003-04-23 | 2006-11-28 | Pfizer Inc. | Cannabiniod receptor ligands and uses thereof |
US7268133B2 (en) * | 2003-04-23 | 2007-09-11 | Pfizer, Inc. Patent Department | Cannabinoid receptor ligands and uses thereof |
US7145012B2 (en) | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
US20040214856A1 (en) * | 2003-04-23 | 2004-10-28 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
CA2524397A1 (en) * | 2003-05-07 | 2004-11-18 | Pfizer Products Inc. | Cannabinoid receptor ligands and uses thereof |
US7232823B2 (en) | 2003-06-09 | 2007-06-19 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
US20040259887A1 (en) * | 2003-06-18 | 2004-12-23 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
FR2856683A1 (fr) * | 2003-06-25 | 2004-12-31 | Sanofi Synthelabo | Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique |
GB0402355D0 (en) * | 2004-02-03 | 2004-03-10 | Glaxo Group Ltd | Novel compounds |
GB0402356D0 (en) * | 2004-02-03 | 2004-03-10 | Glaxo Group Ltd | Novel compounds |
GB0402357D0 (en) * | 2004-02-03 | 2004-03-10 | Glaxo Group Ltd | Novel compounds |
JP2007523207A (ja) * | 2004-02-23 | 2007-08-16 | グラクソ グループ リミテッド | カンナビノイド受容体モジュレーターとしてのピリミジン誘導体 |
WO2005080342A1 (en) * | 2004-02-24 | 2005-09-01 | Glaxo Group Limited | Pyridine derivatives and their use as cb2 receptor modulators |
ITMI20041032A1 (it) * | 2004-05-24 | 2004-08-24 | Neuroscienze S C A R L | Compositi farmaceutici |
MX2007000015A (es) * | 2004-06-22 | 2007-03-07 | Schering Corp | Ligandos de receptor de canabinoide. |
JP2008505965A (ja) | 2004-07-12 | 2008-02-28 | カディラ ヘルスケア リミティド | カンナビノイド受容体修飾因子としての三環式ピラゾール誘導体 |
US20060025448A1 (en) | 2004-07-22 | 2006-02-02 | Cadila Healthcare Limited | Hair growth stimulators |
FR2875230A1 (fr) * | 2004-09-13 | 2006-03-17 | Sanofi Aventis Sa | Derives de pyrazole condense, leur preparation et leur application en therapeutique |
DK1828182T3 (da) * | 2004-11-29 | 2010-05-10 | Warner Lambert Co | Terapeutiske pyrazol[3,4-B]pyridiner og indazoler |
JP2008526887A (ja) * | 2005-01-10 | 2008-07-24 | ユニバーシティ オブ コネチカット | カンナビノイド受容体に作用する新規なヘテロピロール類似体 |
US8853205B2 (en) | 2005-01-10 | 2014-10-07 | University Of Connecticut | Heteropyrrole analogs acting on cannabinoid receptors |
FR2887550A1 (fr) * | 2005-06-24 | 2006-12-29 | Sanofi Aventis Sa | Derives de 1-benzylpyrazole-3-acetamide, leur preparation et leur application en therapeutique |
CN101437398A (zh) * | 2006-03-10 | 2009-05-20 | 詹里恩探索公司 | 用于治疗肥胖症的大麻素受体拮抗剂/反向激动剂 |
WO2007121687A1 (fr) * | 2006-04-26 | 2007-11-01 | Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China | Dérivés du 4-méthyl-1h-diaryl pyrazole et leur utilisation comme médicaments |
US7763607B2 (en) * | 2006-04-27 | 2010-07-27 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators |
EP2026798A1 (en) * | 2006-04-27 | 2009-02-25 | Solvay Pharmaceuticals GmbH | Pharmaceutical compositions comprising cbx cannabinoid receptor modulators and potassium channel modulators |
US20070254863A1 (en) * | 2006-04-27 | 2007-11-01 | Jochen Antel | Use of CBx cannabinoid receptor modulators as potassium channel modulators |
US7875647B2 (en) * | 2006-09-29 | 2011-01-25 | Green Cross Corporation | Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists |
CA2673177A1 (en) | 2006-12-18 | 2008-06-26 | 7Tm Pharma A/S | Modulators of cb1 receptors |
GB0702862D0 (en) * | 2007-02-14 | 2007-03-28 | Univ Aberdeen | Therapeutic compounds |
EP1985295A1 (en) | 2007-04-04 | 2008-10-29 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders |
CN101314591B (zh) * | 2007-05-30 | 2010-09-29 | 上海阳帆医药科技有限公司 | 吡唑类高选择性大麻受体-1拮抗剂和/或反向激动剂 |
FR2916758B1 (fr) * | 2007-06-04 | 2009-10-09 | Sanofi Aventis Sa | Derives de 1-benzylpyrazole, leur preparation et leur application en therapeutique |
EP2176208B1 (en) * | 2007-07-30 | 2015-01-21 | Zynerba Pharmaceuticals, Inc. | Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
WO2009029727A1 (en) * | 2007-08-28 | 2009-03-05 | Vanderbilt University | Cannabinoid receptor targeted agent |
US8133904B2 (en) * | 2007-09-07 | 2012-03-13 | Jenrin Discovery, Inc. | Cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
KR20100072037A (ko) | 2007-09-20 | 2010-06-29 | 애보트 헬스케어 프로덕츠 비.브이. | 칸나비노이드 cb₁수용체 효능제로서의 5-아릴-4,5-디하이드로-(1h)-피라졸 |
US20090247619A1 (en) * | 2008-03-06 | 2009-10-01 | University Of Kentucky | Cannabinoid-Containing Compositions and Methods for Their Use |
US10053444B2 (en) | 2009-02-19 | 2018-08-21 | University Of Connecticut | Cannabinergic nitrate esters and related analogs |
EP2311443A1 (en) | 2009-10-15 | 2011-04-20 | Rheinische Friedrich-Wilhelms-Universität | Pharmaceutical composition containing cannabinoid-receptor 2 antagonists |
CN102329192A (zh) * | 2011-09-30 | 2012-01-25 | 山东天一化学股份有限公司 | 溴化苄的合成方法 |
US10377718B2 (en) * | 2014-06-06 | 2019-08-13 | Research Triangle Institute | Apelin receptor (APJ) agonists and uses thereof |
BR112017026535B1 (pt) | 2015-06-12 | 2023-12-19 | Vettore, LLC | Composto e composição farmacêutica |
MX2019006893A (es) | 2016-12-12 | 2019-10-09 | Vettore Llc | Inhibidores heterociclicos de mct4. |
US10420089B2 (en) | 2017-08-10 | 2019-09-17 | At&T Intellectual Property I, L.P. | Adaptive two-stage downlink control channel structure for code block group based fifth generation (5G) or other next generation systems |
CA3125847A1 (en) | 2020-07-27 | 2022-01-27 | Makscientific, Llc | Process for making biologically active compounds and intermediates thereof |
US12054480B2 (en) | 2020-07-31 | 2024-08-06 | Makscientific, Llc | Compounds for treating cannabinoid toxicity and acute cannabinoid overdose |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5015651A (en) * | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
FR2665898B1 (fr) * | 1990-08-20 | 1994-03-11 | Sanofi | Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
FR2692575B1 (fr) * | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
FR2713225B1 (fr) * | 1993-12-02 | 1996-03-01 | Sanofi Sa | N-pipéridino-3-pyrazolecarboxamide substitué. |
FR2714057B1 (fr) * | 1993-12-17 | 1996-03-08 | Sanofi Elf | Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant. |
-
1995
- 1995-12-08 FR FR9514547A patent/FR2742148B1/fr not_active Expired - Fee Related
-
1996
- 1996-12-06 EP EP96941716A patent/EP0868420B1/fr not_active Expired - Lifetime
- 1996-12-06 AT AT96941716T patent/ATE191211T1/de not_active IP Right Cessation
- 1996-12-06 EP EP98401565A patent/EP0885889A3/fr not_active Withdrawn
- 1996-12-06 NZ NZ323962A patent/NZ323962A/xx not_active IP Right Cessation
- 1996-12-06 DK DK96941716T patent/DK0868420T3/da active
- 1996-12-06 DE DE69607484T patent/DE69607484T2/de not_active Expired - Lifetime
- 1996-12-06 ZA ZA9610299A patent/ZA9610299B/xx unknown
- 1996-12-06 RU RU98112606/04A patent/RU2170230C2/ru not_active IP Right Cessation
- 1996-12-06 AU AU11010/97A patent/AU718763B2/en not_active Ceased
- 1996-12-06 IL IL12480196A patent/IL124801A/en not_active IP Right Cessation
- 1996-12-06 CZ CZ19981775A patent/CZ294307B6/cs not_active IP Right Cessation
- 1996-12-06 CA CA002239489A patent/CA2239489C/en not_active Expired - Fee Related
- 1996-12-06 PL PL96327177A patent/PL186466B1/pl not_active IP Right Cessation
- 1996-12-06 KR KR10-1998-0704296A patent/KR100488610B1/ko not_active IP Right Cessation
- 1996-12-06 US US09/077,767 patent/US5925768A/en not_active Expired - Lifetime
- 1996-12-06 UA UA98062944A patent/UA44913C2/uk unknown
- 1996-12-06 CN CN96199643A patent/CN1101813C/zh not_active Expired - Fee Related
- 1996-12-06 WO PCT/FR1996/001953 patent/WO1997021682A1/fr active IP Right Grant
- 1996-12-06 JP JP52178697A patent/JP3510270B2/ja not_active Expired - Fee Related
- 1996-12-06 SK SK758-98A patent/SK283706B6/sk not_active IP Right Cessation
- 1996-12-06 HU HU9901244A patent/HUP9901244A3/hu unknown
- 1996-12-06 EE EE9800171A patent/EE04674B1/xx not_active IP Right Cessation
- 1996-12-06 BR BR9611986A patent/BR9611986A/pt not_active IP Right Cessation
- 1996-12-06 ES ES96941716T patent/ES2148820T3/es not_active Expired - Lifetime
- 1996-12-06 TR TR1998/01041T patent/TR199801041T2/xx unknown
- 1996-12-06 PT PT96941716T patent/PT868420E/pt unknown
- 1996-12-06 AR ARP960105525A patent/AR004364A1/es active IP Right Grant
- 1996-12-06 SI SI9630209T patent/SI0868420T1/xx unknown
- 1996-12-07 MY MYPI96005160A patent/MY115228A/en unknown
- 1996-12-07 TW TW085115150A patent/TW402594B/zh active
-
1998
- 1998-06-05 NO NO19982589A patent/NO310683B1/no not_active IP Right Cessation
- 1998-06-08 IS IS4765A patent/IS4765A/is unknown
- 1998-06-08 MX MX9804565A patent/MX9804565A/es not_active IP Right Cessation
-
2000
- 2000-06-07 GR GR20000401312T patent/GR3033626T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR004364A1 (es) | Compuesto derivado de pirazol, procedimiento para su preparacion y composicion farmaceutica que lo contiene. | |
NO962540D0 (no) | Rapamycinderivater for anvendelse som immunsuppresjonsmidler | |
GT199900102A (es) | Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen. | |
ES2076688T3 (es) | Derivados de 2-hidroxi-2-feniletilamina utiles como agonistas de beta-3-adrenoceptores. | |
MX9303664A (es) | Nuevos derivados de pirazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
GT199900150A (es) | 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas. | |
ES2164842T3 (es) | Procedimiento para la preparacion de composiciones de microcapsulas. | |
UY28514A1 (es) | Nuevos compuestos | |
UY25242A1 (es) | Inhibidores de benzotiazol de la proteína tirosina cinasa | |
NO965516D0 (no) | Sterolderivater anvendt til regulering av meiose | |
AR013746A1 (es) | Sustitucion bioisosterica de catecol por indazol en compuesto terapeuticos activos | |
AR004498A1 (es) | Compuestos de aminofosfonato y composiciones farmaceuticas que los contienen, el uso de los mismos, y un procedimiento para su preparacion | |
ES2166807T3 (es) | Piridazinonas y su uso como fungicidas. | |
NO942065L (no) | Fosfinyloksymetylketoner som interleukin-1 yminhibitorer | |
UY27894A1 (es) | Derivados de cinamida. | |
ES2067854T3 (es) | Polisulfato de derivado de ciclodextrina y procedimiento para preparar el mismo. | |
FI955643A (fi) | N-alkyylitiopolyaminnijohdannaiset säteilyltä suojaavina aineina | |
DK0799239T3 (da) | Diastereomert rene 3-oxo- og 3-thioxo-4-aza-androstan-derivater og anvendelse deraf som antiandrogener | |
PA8586801A1 (es) | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso | |
ES2191109T3 (es) | Inhibidores de proteasas de guanidino. | |
ES2179529T3 (es) | Compuestos biaromaticos unidos por un radical heteroetinileno, y composiciones farmaceuticas y cosmeticas que los contienen. | |
ES2186989T3 (es) | Cristales de maltitol de formas especificas, compuestos cristalinos que los contienen y procedimientos para su preparacion. | |
ES2185196T3 (es) | Un procedimiento para la preparacion de tetraazamacrociclos. | |
AR003977A1 (es) | Composiciones endoparasiticidas a base de didepsipeptidos, nuevos didepsipeptidos y procedimientos para su produccion. | |
DK1177191T3 (da) | Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |